Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|June 29, 2023
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancerAnna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Pathology, Research and Practice|April 11, 2025
Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancerBenedikt Ebner, Lennert Eismann, Julian Hermans, et al.
Virchows Archiv : an International Journal of Pathology|September 5, 2019
Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytologyMaria Del Carmen Rodriguez Pena, Simeon U Springer, Diana Taheri, et al.
Human Pathology|April 27, 2019
Tumor immune microenvironment in non-muscle-invasive urothelial carcinoma of the bladderMarie-Lisa Eich, Alcides Chaux, Gunes Guner, et al.
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Radiation Oncology (London, England)|April 4, 2024
Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancerSimone Wegen, Karina Claus, Philipp Linde, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
European Urology Oncology|December 31, 2025
Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder CancerNadia Jurczok, Gabriel Dernbach, Benedikt Ebner, et al.
Neuro-Oncology|December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastasesAnna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Pageof 6